Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 1
1998 3
1999 2
2001 2
2002 3
2003 4
2004 1
2005 4
2006 6
2007 5
2008 2
2009 3
2010 7
2011 8
2012 6
2013 4
2014 7
2015 4
2017 5
2018 2
2019 2
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Ron receptor tyrosine kinase signaling as a therapeutic target.
Benight NM, Waltz SE. Benight NM, et al. Among authors: waltz se. Expert Opin Ther Targets. 2012 Sep;16(9):921-31. doi: 10.1517/14728222.2012.710200. Epub 2012 Jul 26. Expert Opin Ther Targets. 2012. PMID: 22834780 Free PMC article. Review.
MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages.
Babicky ML, Harper MM, Chakedis J, Cazes A, Mose ES, Jaquish DV, French RP, Childers B, Alakus H, Schmid MC, Foubert P, Miyamoto J, Holman PJ, Walterscheid ZJ, Tang CM, Varki N, Sicklick JK, Messer K, Varner JA, Waltz SE, Lowy AM. Babicky ML, et al. Among authors: waltz se. Oncogene. 2019 Jul;38(28):5599-5611. doi: 10.1038/s41388-019-0811-9. Epub 2019 Apr 9. Oncogene. 2019. PMID: 30967626 Free PMC article.
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.
Wicker CA, Hunt BG, Krishnan S, Aziz K, Parajuli S, Palackdharry S, Elaban WR, Wise-Draper TM, Mills GB, Waltz SE, Takiar V. Wicker CA, et al. Among authors: waltz se. Cancer Lett. 2021 Apr 1;502:180-188. doi: 10.1016/j.canlet.2020.12.038. Epub 2021 Jan 12. Cancer Lett. 2021. PMID: 33450358 Free PMC article.
81 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page